NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

According to Dr Asif Ahmed, an NHS GP , if you have pain, fatigue or visual problems, which worsen in hot weather, it could ...

Objective To establish a rigorous, expert-led, evidence-based approach to the evaluation of licensed drugs for repurposing and testing in clinical trials of people with progressive multiple sclerosis ...

New research led by a St. Michael’s Hospital clinician-scientist and published in the prestigious New England Journal of ...

Cognitive symptoms, mood disorders, and fatigue manifest differently in relapsing-remitting vs. progressive forms of MS, a ...

The following is a summary of “Secondary progression activity monitoring in MS despite an early highly active treatment the ...